6-49448861-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000274813.4(MMUT):c.1399C>T(p.Arg467Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000409 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000042 ( 0 hom. )
Consequence
MMUT
ENST00000274813.4 stop_gained
ENST00000274813.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 5.32
Genes affected
MMUT (HGNC:7526): (methylmalonyl-CoA mutase) This gene encodes the mitochondrial enzyme methylmalonyl Coenzyme A mutase. In humans, the product of this gene is a vitamin B12-dependent enzyme which catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA, while in other species this enzyme may have different functions. Mutations in this gene may lead to various types of methylmalonic aciduria. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-49448861-G-A is Pathogenic according to our data. Variant chr6-49448861-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 495778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMUT | NM_000255.4 | c.1399C>T | p.Arg467Ter | stop_gained | 7/13 | ENST00000274813.4 | NP_000246.2 | |
MMUT | XM_005249143.4 | c.1399C>T | p.Arg467Ter | stop_gained | 7/13 | XP_005249200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMUT | ENST00000274813.4 | c.1399C>T | p.Arg467Ter | stop_gained | 7/13 | 1 | NM_000255.4 | ENSP00000274813 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151884Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151884
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251284Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135812
GnomAD3 exomes
AF:
AC:
17
AN:
251284
Hom.:
AF XY:
AC XY:
12
AN XY:
135812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461438Hom.: 0 Cov.: 30 AF XY: 0.0000468 AC XY: 34AN XY: 727044
GnomAD4 exome
AF:
AC:
62
AN:
1461438
Hom.:
Cov.:
30
AF XY:
AC XY:
34
AN XY:
727044
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151884Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74166
GnomAD4 genome
AF:
AC:
4
AN:
151884
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Counsyl | Jan 03, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 05, 2018 | The MUT c.1399C>T (p.Arg467Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. This variant has been described in five studies in eight probands with classic methylmalonic acidemia (MMA), with one in a homozygous state and seven in a compound heterozygous state (Peters et al. 2002; Acquaviva et al. 2005; Worgan et al. 2006; Dündar et al. 2012; Liu et al. 2012). The p.Arg467Ter variant was absent from 48 anonymous controls and is reported at a frequency of 0.001320 in the Ashkenazi Jewish population of the Genome Aggregation Database. Functional studies showed that six of the patients (one homozygote and five compound heterozygotes) carrying the p.Arg467Ter variant demonstrated zero enzyme activity ('mut0' phenotype) (Acquaviva et al. 2005). Based on the potential impact of truncating variants and presence in affected individuals, the p.Arg467Ter variant is classified as pathogenic for methylmalonic acidemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 01, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Arg467*) in the MUT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MUT are known to be pathogenic (PMID: 15781192). This variant is present in population databases (rs774159791, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with methylmalonic acidemia (PMID: 12402345, 16281286, 22727635, 26790480). ClinVar contains an entry for this variant (Variation ID: 495778). For these reasons, this variant has been classified as Pathogenic. - |
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Methylmalonic acidemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 11, 2016 | Variant summary: The MUT c.1399C>T variant results into nonsense mutation in exon 7 predicted to cause a loss of protein function due to production of a truncated protein or nonsense-mediated mRNA decay. It was exclusively observed in the Non-Finnish European sub-cohort of the ExAC project at an allele frequency of 0.0015%, which does not exceed the maximal expected allele frequency of a disease-causing MUT allele (0.24%). In the literature, the variant was observed in several patients with methylmalonic aciduria in compound heterozygosity with other truncating as well as missense variants, consistent with a disease-causing nature. Two reputable databases as well as one clinical lab has classified this variant as pathogenic. Considering all evidence, the variant has been classified as a Disease Variant/Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at